drugset / Trial / NCT05792111

Caudal Epidural Steroid and Trigger Point Injection

NCT05792111

Phase 4 Unknown 72 enrolled Abant Izzet Baysal University
RandomizedParallel-groupSingle-blindTreatment

Summary

This prospective randomized study will be conducted in Bolu Abant İzzet Baysal University Hospital. Chronic low back and hip pain 72 patients aged between 18-70 years will be included in the study. The primary output of our study was NRS scores. The study of Manchikanti. L et al. (control group NRS reduction 4.4 ± 1.8; α margin of error 0.05, power 99%) (3) was taken as the basis for determining the sample size. Using the G Power 3 calculator program, 72 patients were identified to reduce their NRS scores by 25%. With a 20% exclusion rate, the total number of patients was calculated as 90

Timeline

Start
2022-10-12
Primary completion
2023-12-20
Completion
2024-12-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified Intramuscular
Background Bupivacaine Other / unclassified 20 mg Other
Background Triamcinolone Other / unclassified 80 mg Other